Abstract: A DC-DC converter circuit with selectable working modes is disclosed. Compared with the traditional chip that works in one mode, the DC-DC converter with selectable working modes adds only a mode selection circuit, so that the chip can work in voltage control mode or current control mode. On the one hand, the applications of the chip are more extensive, and on the other hand, when the applications are different, the cost of developing a DC-DC converter with selectable working mode is greatly reduced compared with the traditional DC-DC converter.

Abstract: The present invention relates to the medical field, and in particular to the use of adefovir dipivoxil and a structural analog thereof for treating pseudorabies virus. In particular, the invention relates to the use of a compound as shown in formula (I), a stereoisomer thereof, a solvate thereof, a pharmaceutically acceptable salt thereof or a solvate of the pharmaceutically acceptable salt thereof for inhibiting the pseudorabies virus, treating pseudorabies virus infections or treating diseases related to pseudorabies virus infections.

Abstract: A voltage-to-time converter (VTC) for a time-domain analog-to-digital converter is disclosed, which provides a time-domain analog-to-digital converter (T-ADC) with low power consumption and high precision. By combining the advantages of current-starving technology, current mirror technology, and body biasing technology, compared with the traditional structure, the VTC and T-ADC achieve excellent performance, such as low power consumption, high linearity, wide input dynamic range, and strong anti-interference to PVT variations. Compared with the traditional voltage-to-time converter, the disclosed voltage-to-time converter has a wider input dynamic range and higher linearity. The input voltage is connected to transistors in the circuit as a body bias, resulting in a very small body current, and no apparent increase in power consumption. The design of a low-power voltage-to-time converter is realized.

Abstract: A pseudorabies virus (PRV) or a modified form thereof, or a genome sequence or a cDNA sequence containing the PRV or the modified form thereof, or nucleic acid molecules of a complementary sequence of the cDNA sequence, for treating tumors of subjects and/or reducing or inhibiting tumor recurrence, and for preparation of a pharmaceutical composition used for treating the tumors of the subjects and/or reducing or inhibiting the tumor recurrence. A method for treating tumors and/or reducing or inhibiting tumor recurrence, comprising a step of administering, on a subject having a need, the PRV or the modified form thereof, or nucleic acid molecules of the genome sequence containing the PRV or the modified form thereof.

Abstract: Provided are a broad-spectrum monoclonal anti-Flu B antibody, cell strains generating the antibody, and a composition comprising the antibody; also provided are uses of the antibody for diagnosing, preventing and/or treating an infection of the Flu B and/or diseases caused by the infection.

Abstract: Provided are a broad-spectrum monoclonal anti-Flu B antibody, cell strains generating the antibody, and a composition comprising the antibody; also provided are uses of the antibody for diagnosing, preventing and/or treating an infection of the Flu B and/or diseases caused by the infection.